NCT06983938View on ClinicalTrials.gov

This Study Will Evaluate the Safety and Potential Complications of Dual ProGlide vs Single ProGlide and Angioseal for Common Femoral Arteriotomy Closure Following Transcatheter Aortic Valve Replacement

NAActive, not recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 12, 2025

Primary Completion Date

August 13, 2025

Study Completion Date

October 15, 2025

Conditions
Transcatheter Aortic Valve ReplacementClosure Technique
Interventions
DEVICE

Double Perclose Proglide

Upon completion of valve replacement, closure will proceed using two Perclose Proglide devices.

DEVICE

Single Perclose Proglide plus Angioseal

Upon completion of valve replacement, closure will proceed using one Perclose Proglide device plus one Angioseal device.

Trial Locations (1)

75093

Baylor Scott & White The Heart Hospital - Plano, Plano

Sponsors
All Listed Sponsors
lead

Baylor Research Institute

OTHER